TCR2 THERAPEUTICS INC (TCRR) Stock Analyst Earnings Estimates
NASDAQ:TCRR - Nasdaq - US87808K1060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 457.34% | N/A 365.49% | N/A 81.55% | N/A 32.85% | N/A -12.72% | ||||||||
| EBITDA YoY % growth | -9.71M | -12.88M -32.65% | -26.03M -102.10% | -50.52M -94.08% | -67.11M -32.84% | -93.254M -38.96% | -119.808M -28.47% | N/A -51.05% | N/A -18.60% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.93M | -13.18M -32.73% | -26.45M -100.68% | -51.38M -94.25% | -68.7M -33.71% | -96.081M -39.86% | -122.854M -27.87% | N/A -4.33% | N/A -18.99% | N/A -10.88% | N/A 5.08% | N/A 44.66% | N/A 109.51% | N/A 802.69% | N/A 19.69% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -6.43 -13.18% | -2.43 62.21% | -2.63 -8.23% | -3.93 -49.43% | N/A 42.95% | N/A 25.27% | N/A 7.76% | N/A 53.80% | N/A | N/A | N/A | N/A |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.65 21.22% | -0.46 42.33% | -0.42 73.19% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -35.088M -10.34% | -35.649M -14.62% | -35.833M -15.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -1.03 -35.53% | -0.69 | -0.34 | -48.50% |
| Q4 2022 Q2Q % growth | -1.56 -116.67% | -0.81 | -0.75 | -93.38% |
| Q3 2022 Q2Q % growth | -0.79 -14.49% | -0.85 | 0.06 | 7.22% |
| Q2 2022 Q2Q % growth | -0.82 -28.12% | -0.81 | -0.01 | -1.76% |
| Q1 2022 Q2Q % growth | -0.76 -31.03% | -0.76 | 0.00 | -0.09% |
| Q4 2021 Q2Q % growth | -0.72 -30.91% | -0.76 | 0.04 | 5.78% |
| Q3 2021 Q2Q % growth | -0.69 -23.21% | -0.66 | -0.03 | -4.25% |
| Q2 2021 Q2Q % growth | -0.64 4.48% | -0.60 | -0.04 | -6.64% |
| Q1 2021 Q2Q % growth | -0.58 10.77% | -0.54 | -0.04 | -8.19% |
| Q4 2020 Q2Q % growth | -0.55 -1.85% | -0.57 | 0.02 | 3.93% |
| Q3 2020 Q2Q % growth | -0.56 3.45% | -0.54 | -0.02 | -3.37% |
| Q2 2020 Q2Q % growth | -0.67 -45.65% | -0.67 | 0.00 | -0.39% |
| Q1 2020 Q2Q % growth | -0.65 86.60% | -0.62 | -0.03 | -5.33% |
| Q4 2019 Q2Q % growth | -0.54 | -0.68 | 0.14 | 20.59% |
| Q3 2019 Q2Q % growth | -0.58 | -0.56 | -0.02 | -3.07% |
| Q2 2019 Q2Q % growth | -0.46 | -0.58 | 0.12 | 21.16% |
| Q1 2019 Q2Q % growth | -4.85 | -0.48 | -4.37 | -911.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -34.75% | 0.13% | 0% | 7.97% |
| Revenue | N/A | N/A | N/A | N/A |